What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment.
AiCure,
Read More
Clinical Trial
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
Microsoft, Adaptive, Providence Partner to Decode COVID-19 Immune Response
What You Should Know:
- Microsoft and Adaptive Biotechnologies have expanded their partnership to map the human immune response to COVID-19 and advance our understanding of the disease.
- Data from this study will be made available through an open-access portal to help researchers, public health organizations and industry improve diagnostics, help triage patients based on the immune response to the disease, and inform vaccine discovery for COVID-19.
- Other industry leaders including
Read More
Scanwell Health Launches Clinical-Grade Rapid At-Home COVID-19 Test Kits
What You Should Know:
- Scanwell Health announced the first clinical-grade rapid at-home test for COVID-19.
- Scanwell secures exclusive rights to license China FDA-cleared rapid serology test from INNOVITA; Partners with nationwide telehealth provider Lemonaid Health to distribute smartphone-enabled tests to individuals in the U.S.
- After a quick screening, eligible patients are sent a kit via next-business-day delivery. Patients take the test at home and
Read More
Fitbit, FibriCheck Expand Partnership to Deliver CE-Marked Heart Health Detection App in Europe
- Fitbit and FibriCheck have expanded their partnership to enable users in France, Germany, Italy, and Spain to monitor their heart rhythm for irregularities, such as Atrial Fibrillation (AFib), directly from their Fitbit smartwatch.
- The partnership was first announced in September 2019, when the FibriCheck app was made available to Fitbit smartwatch users in the UK, Ireland, the Netherlands, and Belgium. Since the app launched on Fitbit OS, more than 150,000 heart rhythm measurements have
Read More
The Many Faces of AI in Clinical Trials
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs.
The
Read More
Sharecare Integrates App-Based Tobacco Cessation Program into Digital Health Platform
- Sharecare integrates MindSciences’ mindfulness-based smoking cessation program called Craving to Quit into their digital health platform.
- The Craving to Quit program targets the neurological function that enables habit formation to instead lead the user to curb tobacco use.
Sharecare, the digital health
company that helps people manage all their health in one place, and MindSciences, the leader in
evidence-based behavior change apps, today announced a partnership to
Read More
UK-Based Startup Oxford VR Nabs $12.5M to Expand Automated VR Therapy Platform
- Automated virtual reality therapy Oxford VR secures a record $12.5M investment to advance its real-world impact in behavioral health, and accelerate clinical leadership in the U.S.
- The investment will enable the next-level growth of pioneering immersive therapy for depression, anxiety, and other behavioral health conditions.
VR therapy pioneer Oxford VR announced today a landmark $12.5 million Series A funding round led by Optum Ventures and supported by Luminous Ventures. The round
Read More
Lumos Diagnostics Raises $15M to Expand Point of Care Diagnostic Solutions Internationally
- Lumos Diagnostics raises $15M in Series A funding to support the international expansion of its point of care diagnostic solutions.
- Lumos provides assay development and manufacturing services for customized POC tests as well as directly develops, manufactures and will commercialize a suite of proprietary Lumos-branded POC tests that focus on the systemic host immune response.
Lumos Diagnostics, a Sarasota, FL-based health IT company, today announced it has raised $15M in Series A
Read More
Notable Launches Observational Clinical Trial for Patients with Blood Cancer
- Notable launches The ANSWer Study, it's new observational clinical trial for patients with blood cancer and is currently enrolling patients.- The primary assessment is to establish a tumor registry with annotated clinical outcomes.Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling patients in its new observational clinical trial. The clinical trial will take place at
Read More
